The United Kingdom approves a Moderna COVID-19 vaccine aimed at targeting the Omicron variant and other variants of SARS-CoV-2, becoming the first country to do so.
The UK has become the first country to approve the use of Moderna’s new vaccine that targets both the original and Omicron variants of Covid. Moderna’s new Covid vaccine was today, Monday, August 15, judged to meet the UK regulator’s standards of safety, quality and effectiveness. It was subsequently approved by the Medicines and Healthcare products Regulatory Agency (MHRA), who released a statement confirming it. Today’s decision means that Britain is the first country to approve the use of this bivalent vaccine that in tests has proved effective against both the original strain plus the Omicron variant.